{"name":"Tengion","permalink":"tengion","crunchbase_url":"http://www.crunchbase.com/company/tengion","homepage_url":"http://www.tengion.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"610-292-8364","description":"","created_at":"Thu Mar 11 06:42:53 UTC 2010","updated_at":"Fri Jul 02 20:23:53 UTC 2010","overview":"<p>Tengion, a clinical-stage biotechnology company, is a leader in developing neo-organs and neo-tissues, currently derived from a patient&#8217;s own (autologous) cells. The Company has completed two Phase 2 human clinical trial in the United States with its Tengion Neo-Bladder Augmentâ„¢ for children with neurogenic bladder due to spina bifida and in adults with neurogenic bladder due to spinal cord injury. A successful academic human clinical experience with a urinary Neo-Bladder Augment was reported in The Lancet in April 2006 by investigators from the Children&#8217;s Hospital Boston. Tengion has an effective investigational new drug application (IND) for its Neo-Urinary Conduitâ„¢ and expects to begin a Phase 1 clinical trial in the first half of 2010 in bladder cancer patients requiring bladder removal.</p>","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$122M","funding_rounds":[{"round_code":"c","source_url":"http://www.tengion.com/news/press/20071015.cfm","source_description":"Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":15,"investments":[{"company":null,"financial_org":{"name":"Deerfield Capital Management","permalink":"deerfield-management","image":{"available_sizes":[[[150,25],"assets/images/resized/0005/8515/58515v1-max-150x150.png"],[[250,43],"assets/images/resized/0005/8515/58515v1-max-250x250.png"],[[283,49],"assets/images/resized/0005/8515/58515v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Bain Capital","permalink":"bain-capital-2","image":{"available_sizes":[[[150,28],"assets/images/resized/0007/2080/72080v1-max-150x150.png"],[[213,41],"assets/images/resized/0007/2080/72080v1-max-250x250.png"],[[213,41],"assets/images/resized/0007/2080/72080v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Johnson & Johnson Development","permalink":"johnson-johnson-development","image":{"available_sizes":[[[150,61],"assets/images/resized/0003/2806/32806v1-max-150x150.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-250x250.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"HealthCap","permalink":"healthcap","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/4096/54096v1-max-150x150.png"],[[250,77],"assets/images/resized/0005/4096/54096v1-max-250x250.png"],[[450,139],"assets/images/resized/0005/4096/54096v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Quaker BioVentures","permalink":"quaker-bioventures","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Oak Investment Partners","permalink":"oak-investment-partners","image":{"available_sizes":[[[150,45],"assets/images/resized/0001/5086/15086v3-max-150x150.png"],[[250,76],"assets/images/resized/0001/5086/15086v3-max-250x250.png"],[[250,76],"assets/images/resized/0001/5086/15086v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"L Capital Partners","permalink":"l-capital-partners","image":{"available_sizes":[[[150,41],"assets/images/resized/0002/9187/29187v1-max-150x150.png"],[[250,68],"assets/images/resized/0002/9187/29187v1-max-250x250.png"],[[265,73],"assets/images/resized/0002/9187/29187v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Horizon Technology Finance Management LLC","permalink":"horizon-technology-finance","image":{"available_sizes":[[[150,31],"assets/images/resized/0003/5674/35674v2-max-150x150.png"],[[250,52],"assets/images/resized/0003/5674/35674v2-max-250x250.png"],[[259,54],"assets/images/resized/0003/5674/35674v2-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Oxford Finance Corporation","permalink":"oxford-finance-corporation","image":{"available_sizes":[[[108,77],"assets/images/resized/0006/0701/60701v1-max-150x150.jpg"],[[108,77],"assets/images/resized/0006/0701/60701v1-max-250x250.jpg"],[[108,77],"assets/images/resized/0006/0701/60701v1-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://www.tengion.com/news/press/20060623.cfm","source_description":"Tengion Inc. Completes $50 Million Series \"B\" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":23,"investments":[{"company":null,"financial_org":{"name":"Bain Capital","permalink":"bain-capital-2","image":{"available_sizes":[[[150,28],"assets/images/resized/0007/2080/72080v1-max-150x150.png"],[[213,41],"assets/images/resized/0007/2080/72080v1-max-250x250.png"],[[213,41],"assets/images/resized/0007/2080/72080v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Quaker BioVentures","permalink":"quaker-bioventures","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Brookside Capital","permalink":"brookside-capital","image":{"available_sizes":[[[150,18],"assets/images/resized/0000/3991/3991v1-max-150x150.png"],[[200,24],"assets/images/resized/0000/3991/3991v1-max-250x250.png"],[[200,24],"assets/images/resized/0000/3991/3991v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Oak Investment Partners","permalink":"oak-investment-partners","image":{"available_sizes":[[[150,45],"assets/images/resized/0001/5086/15086v3-max-150x150.png"],[[250,76],"assets/images/resized/0001/5086/15086v3-max-250x250.png"],[[250,76],"assets/images/resized/0001/5086/15086v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Johnson & Johnson Development","permalink":"johnson-johnson-development","image":{"available_sizes":[[[150,61],"assets/images/resized/0003/2806/32806v1-max-150x150.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-250x250.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"HealthCap","permalink":"healthcap","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/4096/54096v1-max-150x150.png"],[[250,77],"assets/images/resized/0005/4096/54096v1-max-250x250.png"],[[450,139],"assets/images/resized/0005/4096/54096v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"L Capital Partners","permalink":"l-capital-partners","image":{"available_sizes":[[[150,41],"assets/images/resized/0002/9187/29187v1-max-150x150.png"],[[250,68],"assets/images/resized/0002/9187/29187v1-max-250x250.png"],[[265,73],"assets/images/resized/0002/9187/29187v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"a","source_url":"http://phx.corporate-ir.net/phoenix.zhtml?c=218965&p=irol-newsArticle&ID=1431504&highlight=","source_description":"Tengion Inc. Completes $39 Million Series \"A\" Round Financing Will Advance Development of Regenerative Medicine Products","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":3,"investments":[{"company":null,"financial_org":{"name":"Oak Investment Partners","permalink":"oak-investment-partners","image":{"available_sizes":[[[150,45],"assets/images/resized/0001/5086/15086v3-max-150x150.png"],[[250,76],"assets/images/resized/0001/5086/15086v3-max-250x250.png"],[[250,76],"assets/images/resized/0001/5086/15086v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Johnson & Johnson Development Corporation","permalink":"johnson-johnson-development-corporation","image":{"available_sizes":[[[150,57],"assets/images/resized/0005/8402/58402v1-max-150x150.png"],[[225,86],"assets/images/resized/0005/8402/58402v1-max-250x250.png"],[[225,86],"assets/images/resized/0005/8402/58402v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"HealthCap","permalink":"healthcap","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/4096/54096v1-max-150x150.png"],[[250,77],"assets/images/resized/0005/4096/54096v1-max-250x250.png"],[[450,139],"assets/images/resized/0005/4096/54096v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"L Capital Partners","permalink":"l-capital-partners","image":{"available_sizes":[[[150,41],"assets/images/resized/0002/9187/29187v1-max-150x150.png"],[[250,68],"assets/images/resized/0002/9187/29187v1-max-250x250.png"],[[265,73],"assets/images/resized/0002/9187/29187v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"2900 Potshop Lane","address2":"Suite 100","zip_code":"19403","city":"East Norriton","state_code":"PA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":{"valuation_amount":null,"valuation_currency_code":"USD","pub_year":2010,"pub_month":4,"pub_day":9,"stock_symbol":"NASDAQ:TNGN"},"video_embeds":[],"screenshots":[{"available_sizes":[[[150,114],"assets/images/resized/0007/9907/79907v1-max-150x150.jpg"],[[250,190],"assets/images/resized/0007/9907/79907v1-max-250x250.jpg"],[[450,342],"assets/images/resized/0007/9907/79907v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}